Unknown PHASE1 INTERVENTIONAL 2-arm NCT02405637

Simulated Amniotic Fluid In Preventing Feeding Intolerance and Necrotizing Enterocolitis VLBW Neonates

Enteral Administration of a Simulated Amniotic Fluid In Preventing Feeding Intolerance And Necrotizing Enterocolitis In Very Low Birth Weight Neonates

Sponsor: Rania Ali El-Farrash

Conditions Necrotizing Enterocolitis

Interventions distilled water simulated amniotic fluid 20cc/kg/day enterally

Updated 6 times since 2017 Last updated: Mar 28, 2015 Started: Mar 31, 2014 Primary completion: Mar 31, 2015 Completion: May 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Necrotizing Enterocolitis and is currently ongoing. Rania Ali El-Farrash leads this study, which shows 6 recorded versions since 2014 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE1
May 2017 — Jun 2018 [monthly]

Unknown Status PHASE1

Status: Recruiting → Unknown Status

▶ Show 1 earlier version

Jan 2017 — May 2017 [monthly]

Recruiting PHASE1

First recorded

Mar 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Rania Ali El-Farrash

Data source: Ain Shams University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cairo, Egypt